GlassScriptPhysician profile
Elaheh Etedali
NPI 1972535581
$7,831.67
in general payments reported to CMS, 2019-2025
36 companies · $1,346 in 2025
The $1,346 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $717 · 2020: $767 · 2021: $862 · 2022: $1,492 · 2023: $1,141 · 2024: $1,506 · 2025: $1,346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,993.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,993.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $2,077.25 | 2019-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $1,463.81 | 2019-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Abbvie INC. | $630.52 | 2020-2025 | |
| Lilly USA, LLC | $544.13 | 2020-2025 | Mounjaro, Kisunla, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $463.56 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $284.40 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $233.78 | 2019-2022 | |
| Edwards Lifesciences Corporation | $217.31 | 2023-2024 | Sapien 3 Ultra Resilia |
| Eisai INC. | $169.80 | 2020-2024 | |
| Pfizer INC. | $166.40 | 2019-2024 | |
| Sanofi Pasteur INC. | $155.41 | 2020-2022 | |
| Seqirus USA INC | $130.55 | 2022-2025 | Flucelvax |
| Amgen INC. | $128.91 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $126.78 | 2019-2023 | Tradjenta |
| Exact Sciences Corporation | $119.52 | 2023-2025 | Cologuard Collection Kit |
Show all 36 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elaheh Etedali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.